Duo Oncology Options Nanoparticle Platform from University of Pittsburgh

Duo Oncology signed an option to exclusively license nanoparticle prodrug chemistry patented developed in the laboratory of Dr. Song Li and patented by the University of Pittsburgh

©2020 by Duo Oncology, Pittsburgh PA.

  • Twitter
  • LinkedIn